Letter from the Editor

Contributed by:

Taren Grom, Editor

NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable.

PV0315_TarenGromAs we look forward to 2016, there are any number of trends that will impact the life-sciences industry from molecule to market. For our special Year in Preview issue, we have compiled insights from more than 120 industry experts — who represent all areas of the industry — on  10 trends that we believe will impact areas from R&D to commercialization.

As you read this issue, you will no doubt see that the underlying theme is centered around value — value calculations based on outcomes, pricing, R&D, patient adherence, and so on will continue to drive the industry. And this shift to value is critical for patient engagement, the supply chain, M&A, etc.

PwC analysts say the environment in which pharmaceutical and life-sciences companies operate is increasingly challenging and the global need for innovative, cost-effective medicines continues to rise.
Therefore, regulators, payers, healthcare providers, and patients are demanding greater value for money, proven effectiveness of products, and more transparency and access to information.

In the years to come, analysts say a focus on customer experience and engagement will become an increasingly larger portion of the value proposition for products and brands. To provide this value, the industry will need to up its game in terms of relationships, communication, and developing strategies that address the needs and expectations of today’s patients, as well as caregivers, providers, and payers.

According to Astellas’ Jim Robinson the focus on payers will continue as they want to know more about the value of the pharmaceutical products that they are allowing access to and it’s not just about the cost the are seeking data.

And as the era of patient-centricity continues to evolve, adding value beyond the pill becomes even more important. Jay Bolling of PulseCX says if the industry wants to engage target audiences it must move away from pushing brand features and benefits and create immersive customer experiences.

And those customer experiences, says Baxalta’s Brian Goff, can be  based on data, as the industry is learning more and more about how much patients value individualized support that can help reduce the burden of the disease on their daily lives.

It’s the relevancy of the connection points along the patient journey that will create value beyond the efficacy and safety of the treatment says Jim McDonough from Frontline Medical Communications.

And the value being created by pharmaceutical companies needs to be visible. Mark Timney of Purdue Pharma says it is critical for the industry to focus on and communicate the very real value that companies create for their patients and society.

As we look forward to seeing what unfolds in the coming year,
PharmaVOICE also looks forward to its 15th anniversary and sharing a fun retrospective of some of the driving trends that have shaped the industry. Thanks for sharing the journey.

Taren Grom
Editor
~~~~~~~~~~~~~~~~~~~~~~~~~

Their word…

Denise MyshkoPV1115_Theirword
Managing Editor

Progress in technology, coupled with medical and scientific advances, is going to disrupt the healthcare environment, bringing new tools and breakthroughs to patients.

Robin Robinson
Senior Editor

2016 will shine the light on increasing use of patient engagement strategies, a long-term approach to mobile, and new insights driven by big data analytics.

Kim Ribbink
Features Editor

As the world starts to emerge from economic downturn and other challenges, the pharma industry is recognizing more opportunities in established and new markets.
~~~~~~~~~~~~~~~~~~~~~~~~~
Masthead

Volume 15 • Number 10
Publisher    Lisa Banket
Editor    Taren Grom
Creative Director    Marah Walsh

Managing Editor
Denise Myshko

Senior Editor
Robin Robinson

Features Editor
Kim Ribbink

Design Associate
Ariel Medel

Director of Sales
Cathy Tracy

National Account Manager
Suzanne Besse

Webcast Network Producer
Daniel Limbach

Circulation Assistant
Kathy Deiuliis

Copyright 2015
by PharmaLinx LLC, Titusville, NJ
Printed in the U.S.A.
Volume Fifteen, Number Ten

PharmaVoice (ISSN: 1932961X) is published monthly except joint issues in July/Aug. and Nov./Dec., by ­Pharma­­Linx LLC, P.O. Box 327, Titusville, NJ 08560. ­Periodicals postage paid at Titusville, NJ 08560 and additional mailing offices.

Postmaster: Send address changes to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345.

PharmaVoice Coverage and Distribution:
Domestic subscriptions are available at $190 for one year (10 issues). Foreign subscriptions: 10 issues US$360. Contact PharmaVoice at P.O. Box 327, Titusville, NJ 08560. Call us at 609.730.0196 or FAX your order to 609.730.0197.

Contributions: PharmaVoice is not responsible for unsolicited contributions of any type. Unless otherwise agreed in writing, PharmaVoice retains all rights on material published in PharmaVoice for a period of six months after publication and reprint rights after that period expires. E-mail: tgrom@pharmavoice.com.

Change of address: Please allow six weeks for a change of address. Send your new address along with your subscription label to PharmaVoice, P.O. Box 292345, Kettering, OH 45429-0345. Call us at 800.607.4410 or FAX your change to 937.890.0221. E-mail: mwalsh@pharmavoice.com.

Important notice: The post office will not forward copies of this magazine. PharmaVoice is not responsible for replacing undelivered copies due to lack of or late notification of address change.

Advertising in PharmaVoice: To advertise in Pharma­­Voice please contact our Advertising ­Department at P.O. Box 327, Titusville, NJ 08560, or ­telephone us at 609.730.0196. E-mail: lbanket@pharmavoice.com.

Posted in:

Post a Comment

You must be logged in to post a Comment.

FEEDBACK